{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T09:38:14Z","timestamp":1780565894596,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001868","name":"National Science Council Taiwan","doi-asserted-by":"publisher","award":["NSC 103-2314-B-002-057-MY3"],"award-info":[{"award-number":["NSC 103-2314-B-002-057-MY3"]}],"id":[{"id":"10.13039\/501100001868","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13023-016-0446-7","type":"journal-article","created":{"date-parts":[[2016,5,16]],"date-time":"2016-05-16T22:40:56Z","timestamp":1463438456000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Slow, progressive myopathy in neonatally treated patients with infantile-onset Pompe disease: a muscle magnetic resonance imaging study"],"prefix":"10.1186","volume":"11","author":[{"given":"Steven Shinn-Forng","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuh-Liang","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni-Chung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuu-Jen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hui","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Hsiu","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,17]]},"reference":[{"key":"446_CR1","first-page":"3389","volume-title":"The metabolic and molecular bases of inherited disease","author":"R Hirschhorn","year":"2001","unstructured":"Hirschhorn R, Reuser A. Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency. In: Scriver C, Beaudet A, Sly W, Valle D, editors. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill; 2001. p. 3389\u2013420.","edition":"8"},{"issue":"9227","key":"446_CR2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(00)02533-2","volume":"356","author":"H Hout Van den","year":"2000","unstructured":"Van den Hout H, Reuser AJ, Vulto AG, Loonen MC, Cromme-Dijkhuis A, Van der Ploeg AT. Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Lancet. 2000;356(9227):397\u20138.","journal-title":"Lancet"},{"issue":"16","key":"446_CR3","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1073\/pnas.96.16.8861","volume":"96","author":"A Amalfitano","year":"1999","unstructured":"Amalfitano A, McVie-Wylie AJ, Hu H, Dawson TL, Raben N, Plotz P, et al. Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase. Proc Natl Acad Sci U S A. 1999;96(16):8861\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"446_CR4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1750-1172-8-90","volume":"8","author":"SN Prater","year":"2013","unstructured":"Prater SN, Patel TT, Buckley AF, Mandel H, Vlodavski E, Banugaria SG, et al. Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy. Orphanet J Rare Dis. 2013;8(1):90. doi: 10.1186\/1750-1172-8-90 .","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"446_CR5","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1542\/peds.2007-2222","volume":"122","author":"YH Chien","year":"2008","unstructured":"Chien YH, Chiang SC, Zhang XK, Keutzer J, Lee NC, Huang AC, et al. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program. Pediatrics. 2008;122(1):e39\u201345. doi: 10.1542\/peds.2007-2222 .","journal-title":"Pediatrics"},{"key":"446_CR6","doi-asserted-by":"crossref","unstructured":"Chien YH, Lee NC, Chen CA, Tsai FJ, Tsai WH, Shieh JY et al. Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by newborn screening and treated since birth. J Pediatr. 2015;166(4):985\u201391 e1-2. doi: 10.1016\/j.jpeds.2014.10.068","DOI":"10.1016\/j.jpeds.2014.10.068"},{"issue":"1","key":"446_CR7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ajmg.c.31320","volume":"160C","author":"SP Young","year":"2012","unstructured":"Young SP, Piraud M, Goldstein JL, Zhang H, Rehder C, Laforet P, et al. Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques. Am J Med Genet C Semin Med Genet. 2012;160C(1):50\u20138. doi: 10.1002\/ajmg.c.31320 .","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"7","key":"446_CR8","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/GIM.0b013e3181a87867","volume":"11","author":"SP Young","year":"2009","unstructured":"Young SP, Zhang H, Corzo D, Thurberg BL, Bali D, Kishnani PS, et al. Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker. Genet Med. 2009;11(7):536\u201341. doi: 10.1097\/GIM.0b013e3181a87867 .","journal-title":"Genet Med"},{"issue":"6","key":"446_CR9","doi-asserted-by":"crossref","first-page":"e1116","DOI":"10.1542\/peds.2008-3667","volume":"124","author":"YH Chien","year":"2009","unstructured":"Chien YH, Lee NC, Thurberg BL, Chiang SC, Zhang XK, Keutzer J, et al. Pompe disease in infants: improving the prognosis by newborn screening and early treatment. Pediatrics. 2009;124(6):e1116\u201325. doi: 10.1542\/peds.2008-3667 .","journal-title":"Pediatrics"},{"issue":"4","key":"446_CR10","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ymgme.2010.08.001","volume":"101","author":"N Raben","year":"2010","unstructured":"Raben N, Ralston E, Chien YH, Baum R, Schreiner C, Hwu WL, et al. Differences in the predominance of lysosomal and autophagic pathologies between infants and adults with Pompe disease: implications for therapy. Mol Genet Metab. 2010;101(4):324\u201331. doi: 10.1016\/j.ymgme.2010.08.001 .","journal-title":"Mol Genet Metab"},{"issue":"11","key":"446_CR11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.nmd.2011.06.748","volume":"21","author":"RY Carlier","year":"2011","unstructured":"Carlier RY, Laforet P, Wary C, Mompoint D, Laloui K, Pellegrini N, et al. Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: Involvement patterns. Neuromuscul Disord. 2011;21(11):791\u20139. doi: 10.1016\/j.nmd.2011.06.748 .","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"446_CR12","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/mus.24437","volume":"51","author":"JJ Horvath","year":"2015","unstructured":"Horvath JJ, Austin SL, Case LE, Greene KB, Jones HN, Soher BJ, et al. Correlation between quantitative whole-body muscle magnetic resonance imaging and clinical muscle weakness in pompe disease. Muscle Nerve. 2015;51(5):722\u201330. doi: 10.1002\/mus.24437 .","journal-title":"Muscle Nerve"},{"issue":"3","key":"446_CR13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.pediatrneurol.2011.12.010","volume":"46","author":"YH Chien","year":"2012","unstructured":"Chien YH, Lee NC, Huang PH, Lee WT, Thurberg BL, Hwu WL. Early pathologic changes and responses to treatment in patients with later-onset Pompe disease. Pediatr Neurol. 2012;46(3):168\u201371. doi: 10.1016\/j.pediatrneurol.2011.12.010 .","journal-title":"Pediatr Neurol"},{"key":"446_CR14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2051-5960-2-2","volume":"2","author":"EJ Feeney","year":"2014","unstructured":"Feeney EJ, Austin S, Chien YH, Mandel H, Schoser B, Prater S, et al. The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patients. Acta neuropathologica communications. 2014;2:2. doi: 10.1186\/2051-5960-2-2 .","journal-title":"Acta neuropathologica communications"},{"issue":"2","key":"446_CR15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jmri.20804","volume":"25","author":"E Mercuri","year":"2007","unstructured":"Mercuri E, Pichiecchio A, Allsop J, Messina S, Pane M, Muntoni F. Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging. 2007;25(2):433\u201340. doi: 10.1002\/jmri.20804 .","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"446_CR16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/1363849031000139298","volume":"6","author":"SM Haley","year":"2003","unstructured":"Haley SM, Fragala MA, Aseltine R, Ni P, Skrinar AM. Development of a disease-specific disability instrument for Pompe disease. Pediatr Rehabil. 2003;6(2):77\u201384. doi: 10.1080\/1363849031000139298 .","journal-title":"Pediatr Rehabil"},{"issue":"2","key":"446_CR17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/mus.24257","volume":"50","author":"YH Chien","year":"2014","unstructured":"Chien YH, Lee NC, Tsai YJ, Thurberg BL, Tsai FJ, Hwu WL. Prominent vacuolation of the eyelid levator muscle in an early-treated child with infantile-onset Pompe disease. Muscle Nerve. 2014;50(2):301\u20132. doi: 10.1002\/mus.24257 .","journal-title":"Muscle Nerve"},{"issue":"1","key":"446_CR18","first-page":"10","volume":"1","author":"SC Wens","year":"2015","unstructured":"Wens SC, van Doeveren TE, Lequin MH, van Gelder CM, Verdijk RM, van der Hout HJ, et al. Muscle MRI in classic infantile Pompe disease. J Rare Disord: Diagn Therapy. 2015;1(1):10\u20133.","journal-title":"J Rare Disord: Diagn Therapy"},{"issue":"4","key":"446_CR19","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2214\/ajr.179.4.1790989","volume":"179","author":"WP Chan","year":"2002","unstructured":"Chan WP, Liu GC. MR imaging of primary skeletal muscle diseases in children. AJR Am J Roentgenol. 2002;179(4):989\u201397. doi: 10.2214\/ajr.179.4.1790989 .","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"446_CR20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.nmd.2003.08.003","volume":"14","author":"A Pichiecchio","year":"2004","unstructured":"Pichiecchio A, Uggetti C, Ravaglia S, Egitto MG, Rossi M, Sandrini G, et al. Muscle MRI in adult-onset acid maltase deficiency. Neuromuscul Disord. 2004;14(1):51\u20135.","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"446_CR21","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.nmd.2008.02.006","volume":"18","author":"N Dlamini","year":"2008","unstructured":"Dlamini N, Jan W, Norwood F, Sheehan J, Spahr R, Al-Sarraj S, et al. Muscle MRI findings in siblings with juvenile-onset acid maltase deficiency (Pompe disease). Neuromuscul Disord. 2008;18(5):408\u20139. doi: 10.1016\/j.nmd.2008.02.006 .","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"446_CR22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.braindev.2011.05.013","volume":"34","author":"K Ishigaki","year":"2012","unstructured":"Ishigaki K, Yoshikawa Y, Kuwatsuru R, Oda E, Murakami T, Sato T, et al. High-density CT of muscle and liver may allow early diagnosis of childhood-onset Pompe disease. Brain Dev. 2012;34(2):103\u20136. doi: 10.1016\/j.braindev.2011.05.013 .","journal-title":"Brain Dev"},{"issue":"3","key":"446_CR23","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/mus.880150323","volume":"15","author":"J Lexell","year":"1992","unstructured":"Lexell J, Sjostrom M, Nordlund AS, Taylor CC. Growth and development of human muscle: a quantitative morphological study of whole vastus lateralis from childhood to adult age. Muscle Nerve. 1992;15(3):404\u20139. doi: 10.1002\/mus.880150323 .","journal-title":"Muscle Nerve"},{"issue":"9","key":"446_CR24","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/sj.ijo.0800476","volume":"21","author":"AD Kriketos","year":"1997","unstructured":"Kriketos AD, Baur LA, O\u2019Connor J, Carey D, King S, Caterson ID, et al. Muscle fibre type composition in infant and adult populations and relationships with obesity. Int J Obes Relat Metab Disord. 1997;21(9):796\u2013801.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"Suppl 1","key":"446_CR25","first-page":"S42","volume":"47","author":"L Shea","year":"2009","unstructured":"Shea L, Raben N. Autophagy in skeletal muscle: implications for Pompe disease. Int J Clin Pharmacol Ther. 2009;47 Suppl 1:S42\u20137.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"3","key":"446_CR26","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1148\/radiographics.15.3.7624563","volume":"15","author":"EM Adams","year":"1995","unstructured":"Adams EM, Chow CK, Premkumar A, Plotz PH. The idiopathic inflammatory myopathies: spectrum of MR imaging findings. Radiographics. 1995;15(3):563\u201374. doi: 10.1148\/radiographics.15.3.7624563 .","journal-title":"Radiographics"},{"issue":"3","key":"446_CR27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/nbm.2851","volume":"26","author":"I Arpan","year":"2013","unstructured":"Arpan I, Forbes SC, Lott DJ, Senesac CR, Daniels MJ, Triplett WT, et al. T(2) mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross-sectional study of lower leg muscles in 5-15-year-old boys with Duchenne muscular dystrophy. NMR Biomed. 2013;26(3):320\u20138. doi: 10.1002\/nbm.2851 .","journal-title":"NMR Biomed"},{"issue":"3","key":"446_CR28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10545-015-9825-9","volume":"38","author":"PG Carlier","year":"2015","unstructured":"Carlier PG, Azzabou N, de Sousa PL, Hicks A, Boisserie JM, Amadon A, et al. Skeletal muscle quantitative nuclear magnetic resonance imaging follow-up of adult Pompe patients. J Inherit Metab Dis. 2015;38(3):565\u201372. doi: 10.1007\/s10545-015-9825-9 .","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"446_CR29","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1148\/radiology.181.1.1887044","volume":"181","author":"E Kerviler de","year":"1991","unstructured":"de Kerviler E, Leroy-Willig A, Jehenson P, Duboc D, Eymard B, Syrota A. Exercise-induced muscle modifications: study of healthy subjects and patients with metabolic myopathies with MR imaging and P-31 spectroscopy. Radiology. 1991;181(1):259\u201364. doi: 10.1148\/radiology.181.1.1887044 .","journal-title":"Radiology"},{"issue":"2","key":"446_CR30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2214\/ajr.161.2.8333376","volume":"161","author":"P Jehenson","year":"1993","unstructured":"Jehenson P, Leroy-Willig A, de Kerviler E, Duboc D, Syrota A. MR imaging as a potential diagnostic test for metabolic myopathies: importance of variations in the T2 of muscle with exercise. AJR Am J Roentgenol. 1993;161(2):347\u201351. doi: 10.2214\/ajr.161.2.8333376 .","journal-title":"AJR Am J Roentgenol"},{"key":"446_CR31","author":"JM Morrow","year":"2015","unstructured":"Morrow JM, Sinclair CD, Fischmann A, Machado PM, Reilly MM, Yousry TA, et al. MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study. Lancet Neurol. 2015. doi: 10.1016\/S1474-4422(15)00242-2 .","journal-title":"Lancet Neurol"},{"issue":"1","key":"446_CR32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/mus.21304","volume":"40","author":"A Pichiecchio","year":"2009","unstructured":"Pichiecchio A, Poloni GU, Ravaglia S, Ponzio M, Germani G, Maranzana D, et al. Enzyme replacement therapy in adult-onset glycogenosis II: is quantitative muscle MRI helpful? Muscle Nerve. 2009;40(1):122\u20135. doi: 10.1002\/mus.21304 .","journal-title":"Muscle Nerve"},{"key":"446_CR33","author":"CM Gelder van","year":"2016","unstructured":"van Gelder CM, Poelman E, Plug I, Hoogeveen-Westerveld M, van der Beek NA, Reuser AJ, et al. Effects of a higher dose of alglucosidase alfa on ventilator-free survival and motor outcome in classic infantile Pompe disease: an open-label single-center study. J Inherit Metab Dis. 2016. doi: 10.1007\/s10545-015-9912-y .","journal-title":"J Inherit Metab Dis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-016-0446-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T09:46:07Z","timestamp":1498297567000},"score":1,"resource":{"primary":{"URL":"http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-016-0446-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,17]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["446"],"URL":"https:\/\/doi.org\/10.1186\/s13023-016-0446-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,17]]},"article-number":"63"}}